Cancer-Cachexia-Induced Human Skeletal Muscle Myotube Degeneration Is Prevented via Cannabinoid Receptor 2 Agonism In Vitro.

Noone, John; Rooney, Mary F; Karavyraki, Marilena; Yates, Andrew; O'Sullivan, Saoirse E; Porter, Richard K

Noone, John; Rooney, Mary F; Karavyraki, Marilena; Yates, Andrew; O'Sullivan, Saoirse E; Porter, Richard K.

Afiliação

Noone J; School of Biochemistry & Immunology, Trinity College Dublin, D02R590 Dublin, Ireland.
Rooney MF; School of Biochemistry & Immunology, Trinity College Dublin, D02R590 Dublin, Ireland.
Karavyraki M; School of Biochemistry & Immunology, Trinity College Dublin, D02R590 Dublin, Ireland.
Yates A; Artelo Bioscience, Ltd., Alderly Edge, Cheshire SK10 4TG, UK.
O'Sullivan SE; Artelo Bioscience, Ltd., Alderly Edge, Cheshire SK10 4TG, UK.
Porter RK; School of Biochemistry & Immunology, Trinity College Dublin, D02R590 Dublin, Ireland.

Pharmaceuticals (Basel) ; 16(11)2023 Nov 08.

Article em En | MEDLINE | ID: mdl-38004445

Palavras-chave

ART27.13; CAReS; CB1R; CB2R; cancer-induced cachexia; cannabinoids; myotube degeneration

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irlanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irlanda